抗炎症治療の改良された細胞標的指向化用の免疫細胞特異的マクロライド化合物と抗炎症性化合物との複合体

Title:

抗炎症治療の改良された細胞標的指向化用の免疫細胞特異的マクロライド化合物と抗炎症性化合物との複合体

Document Type and Number:

Japanese Patent JP2004518670

Kind Code:

A

Abstract:

The present invention relates to novel compounds represented by the structure I and pharmaceutical preparations thereof for the treatment of inflammatory diseases in humans and animals.

More Like This:

JPH03145423	PHARMACEUTICAL COMPOSITION FOR TREATING FUNCTIONAL DISORDER OF STOMACH AND INTESTINES
WO/2013/113000	DETECTION OF DNA SEQUENCES AS RISK FACTORS FOR HIV INFECTION
WO1999063929	MULTIBINDING INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFERASE PROTEIN

Inventors:

Mercep, Mulden
Methic, Milan
Thomas Kovuk, Linda
Commack, Mariana
Harelves Asic, Boska
Markovic, Stribol

Application Number:

JP2002556599A

Publication Date:

June 24, 2004

Filing Date:

January 03, 2002

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Priva Deionitsuko Dorstuvoo

International Classes:

A61K31/7052; A61P1/04; A61P5/44; A61P11/02; A61P11/06; A61P17/00; A61P17/04; A61P17/06; A61P19/02; A61P27/14; A61P29/00; A61P37/08; C07J17/00; A61K31/7048; C07J43/00; (IPC1-7): C07J17/00; A61K31/7048; A61K31/7052; A61P1/04; A61P11/02; A61P11/06; A61P17/00; A61P17/04; A61P17/06; A61P19/02; A61P27/14; A61P29/00; A61P37/08

Attorney, Agent or Firm:

Shigeru Yagida
Takao Hamano
Morita Tetsuji

Previous Patent: ４−アリール置換インドリノン

Next Patent: ニューロキニン受容体アンタゴニストとしてのテトラヒドロピラン誘導体